Seven top pharmas posted revenue declines in Q1. The common thread? All are US firms
After a fourth quarter in which revenue boomed throughout the biopharma industry, there were reversals for several drugmakers in the first three months of 2025. In Q1, seven large pharma companies saw their revenue decrease year over year, all from the United States.
After a fourth quarter in which revenue boomed throughout the biopharma industry, there were reversals for several drugmakers in the first three months of 2025. In Q1, seven large pharma companies saw their revenue decrease year over year, all from the United States.
